⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12238366 | 1.00 | — | — | |
| SCHEMBL22931283 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL6206809 | 0.97 | — | — | |
| SCHEMBL11136121 | 0.82 | — | — | |
| SCHEMBL10238446 | 0.82 | — | — | |
| SCHEMBL2872031 | 0.65 | — | — | |
| SCHEMBL17773099 | 0.63 | — | — | |
| SCHEMBL3695688 | 0.62 | — | — | |
| SCHEMBL21676090 | 0.62 | — | — | |
| SCHEMBL3562022 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608811-A1 | PROCESS FOR PREPARING 3-AMINO-1-BUTANOL | Advancion Corporation (US) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024146920-A1 | DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS | ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024146902-A1 | METHODS OF PRODUCING HYDROGEL MICROSPHERES | ASCENDIS PHARMA A/S (DK) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024133815-A1 | ANTIBODY-DRUG CONJUGATES WITH MASKED PBD DIMERS | SYNAFFIX B.V. (NL) | 2024-06-27 | — | — | WO | disclosed |
| WO-2024091517-A1 | PROCESS FOR PREPARING 3-AMINO-1-BUTANOL | ADVANCION CORPORATION (US) | 2024-05-02 | — | — | WO | disclosed |
| US-20230355791-A1 | GLYCAN-CONJUGATED ANTIBODIES BINDING TO FC-GAMMA RECEPTOR | SYNAFFIX B.V. (NL) | 2023-11-09 | — | — | US | disclosed |
| US-20230355791-A1 | GLYCAN-CONJUGATED ANTIBODIES BINDING TO FC-GAMMA RECEPTOR | SYNAFFIX B.V. (NL) | 2023-11-09 | — | — | US | disclosed |
| US-20230331724-A1 | PROCESSES FOR PREPARING A DIAZABICYCLOOCTANE COMPOUND | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2023180485-A1 | ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING TROP-2 | SYNAFFIX B.V. (NL) | 2023-09-28 | — | — | WO | disclosed |
| WO-2023180490-A1 | ANTIBODY-CONJUGATES FOR TARGETING OF TUMOURS EXPRESSING NECTIN-4 | SYNAFFIX B.V. (NL) | 2023-09-28 | — | — | WO | disclosed |
| US-20120077840-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE AS GLYCOGEN SYNTHASE KINASE-3 INHIBITORS | ABBOTT GMBH & CO. KG (DE) | 2012-03-29 | — | — | US | disclosed |
| EP-2394995-A1 | RING-FUSED 2-PYRIDONE DERIVATIVES AND HERBICIDES | Kumiai Chemical Industry CO., LTD. (JP) | 2011-12-14 | — | — | EP | disclosed |
| US-20110301355-A1 | Amidine compounds and herbicides | NIPPON SODA CO., LTD. (JP) | 2011-12-08 | — | — | US | disclosed |
| US-20110301355-A1 | Amidine compounds and herbicides | NIPPON SODA CO., LTD. (JP) | 2011-12-08 | — | — | US | disclosed |
| WO-2010023609-A1 | OXAZOLE, OXADIAZOLE AND THIAZOLE DERIVATIVES AS DIACYLGLYCEROL ACYLTRANFERASE INHIBITORS | PIRAMAL LIFE SCIENCES LIMITED (IN) | 2010-03-04 | — | — | WO | disclosed |
| EP-1911350-A1 | AMIDINE COMPOUND AND HERBICIDE | NIPPON SODA CO., LTD. (JP) | 2008-04-16 | — | — | EP | disclosed |
| EP-1501832-A1 | TRIAZOLOPYRIMIDINES | Bayer CropScience AG (DE) | 2005-02-02 | — | — | EP | disclosed |
| CN-1137886-C | 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives | ��˹��ŵ�� | 2004-02-11 | — | — | CN | disclosed |
| WO-2003091254-A1 | TRIAZOLOPYRIMIDINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-11-06 | — | — | WO | disclosed |
| CN-1193968-A | 2,3-dioxo-1,2,3,4-tetrahydro-quinoyxalinyl derivatives | NOVARTIS AG (CH) | 1998-09-23 | — | — | CN | disclosed |